BCM
CRXT

Bridgeway Capital Management’s Clarus Therapeutics Holdings, Inc. Common Stock CRXT Stock Holding History

Bridgeway Capital Management’s Portfolio CRXT Stock Details CRXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-45,000
Closed -$17K – 1476
2022
Q2 		$17K Sell
45,000
-45,000
-50% -$17K ﹤0.01% 1313
2022
Q1 		$134K Buy
+90,000
New +$134K ﹤0.01% 1232